Evidencia
Esta página contiene una instantánea del contenido destacado que pone de relieve las evidencias que abordan cuestiones clínicas fundamentales, incluidas las áreas de incertidumbre. Consulte la lista de referencias del tema principal para conocer todas las fuentes en las que se basa este tema.
Respuestas clínicas Cochrane
Las Respuestas Clínicas de la Cochrane (CCA) proporcionan un punto de entrada legible, sencillo y con enfoque clínico a la investigación rigurosa de las revisiones sistemáticas de la Cochrane. Están diseñadas para ser procesables e informar sobre la toma de decisiones en el punto de atención médica y se han añadido a las secciones pertinentes del texto principal de las Best Practice.
- What are the effects of interventions to improve inhaler technique in children with asthma?
- In children with chronic asthma, what are the benefits and harms of adding long-acting beta2-agonists compared with adding anti-leukotrienes to inhaled corticosteroids?
- How do anti-leukotriene agents compare with inhaled corticosteroids in the management of recurrent and/or chronic asthma in children?
- How does ciclesonide compare with other inhaled corticosteroids in children and adolescents with chronic asthma?
- What adverse events are associated with formoterol when used for the regular treatment of chronic asthma?
- What are the benefits and harms of adding anti‐leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma?
- For children with asthma, can exhaled nitric oxide levels help to guide treatment?
- What are the benefits and harms of home telemonitoring and remote feedback between clinic visits in people with asthma?
- What are the effects of home‐based educational interventions for children with asthma?
- What are the effects of school‐based interventions for children and adolescents with asthma?
- Does asthma education for school staff benefit children with asthma?
- In people with mild to moderate asthma, how do flu vaccines affect asthma symptoms?
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad